INTERNATIONAL PATENT: PRIMELINK BIOTHERAPEUTICS (SHENZHEN) CO., LTD. FILES APPLICATION FOR "CLDN6 ANTIBODY AND CONJUGATES AND USE THEREOF"

GENEVA, Jan. 26 -- PRIMELINK BIOTHERAPEUTICS (SHENZHEN) CO., LTD. (503, Building 1, Yinxing Life Health Science And Technology Park, No.19 Linhui Road, Jinsha Community, Kengzi Street, Pingshan DistrictShenzhen, Guangdong 518118) filed a patent application (PCT/CN2025/109060) for "CLDN6 ANTIBODY AND CONJUGATES AND USE THEREOF" on Jul 17, 2025. With publication no. WO/2026/017108, the details related to the patent application was published on Jan 22, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LU, Yingdong (Room D101, Building 4, 208 Tongyuan Road, Suzhou Industrial Park DistrictSuzhou, J...